Clinical Trial Update: A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study [Phase 3]

View source ↗

Summary

Phase 3 trial status update for patients previously enrolled in a Hoffmann-La Roche/Genentech-sponsored atezolizumab study; the trial is active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING